AU2002353147A1 - 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer - Google Patents

3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer

Info

Publication number: AU2002353147A1
Authority: AU; Australia
Prior art keywords: phenyl; cancer; alkoxy; treatment; kinase inhibitors
Prior art date: 2001-12-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002353147A

Other languages

English (en)

Other versions

AU2002353147A8 (en

Inventor

Jason N. Abrams

Robert Diebold

Jurgen Dinges

John P. Fischer

Viraj Gandhi

Vincent L. Giranda

Jianchun Gong

Charles Hutchins

Qun Li

Tongmei Li

Garrick Packard

Saul H. Rosenberg

Xiaohong Song

Vincent S. Stoll

Sheela A. Thomas

Keith W. Woods

Gui-Dong Zhu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Abbott Laboratories

Original Assignee

Abbott Laboratories

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-13

Filing date

2002-12-12

Publication date

2003-06-30

2002-11-18 Priority claimed from US10/295,833 external-priority patent/US20030187026A1/en

2002-12-12 Application filed by Abbott Laboratories filed Critical Abbott Laboratories

2003-06-30 Publication of AU2002353147A1 publication Critical patent/AU2002353147A1/en

2003-06-30 Publication of AU2002353147A8 publication Critical patent/AU2002353147A8/xx

Status Abandoned legal-status Critical Current

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US2336301A	2001-12-13	2001-12-13
US10/023,363		2001-12-13
US10/295,833		2002-11-18
US10/295,833 US20030187026A1 (en)	2001-12-13	2002-11-18	Kinase inhibitors
PCT/US2002/039915 WO2003051366A2 (en)	2001-12-13	2002-12-12	3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer

Publications (2)

Publication Number	Publication Date
AU2002353147A1 true AU2002353147A1 (en)	2003-06-30
AU2002353147A8 AU2002353147A8 (en)	2003-06-30

Family

ID=32852863

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002353147A Abandoned AU2002353147A1 (en)	2001-12-13	2002-12-12	3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer

Country Status (6)

Country	Link
EP (1)	EP1463505A2 (zh)
JP (1)	JP2005516927A (zh)
AU (1)	AU2002353147A1 (zh)
CA (1)	CA2470214A1 (zh)
MX (1)	MXPA04005810A (zh)
TW (1)	TW200301122A (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003097610A1 (en) *	2002-05-17	2003-11-27	Pharmacia Italia S.P.A.	Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
MX2008012482A (es) *	2006-03-31	2008-10-10	Abbott Lab	Compuestos de indazol.
JP2010516680A (ja) *	2007-01-19	2010-05-20	エックスカバリー，インコーポレイテッド	キナーゼ阻害薬化合物
DE102007026341A1 (de) *	2007-06-06	2008-12-11	Merck Patent Gmbh	Benzoxazolonderivate
WO2009073300A1 (en) *	2007-11-02	2009-06-11	Vertex Pharmaceuticals Incorporated	[1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
JP2011511005A (ja) *	2008-02-04	2011-04-07	オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド	２−アミノピリジン系キナーゼ阻害薬
CA2725014C (en) *	2008-05-30	2014-06-17	Amgen Inc.	Inhibitors of pi3 kinase
GB201216017D0 (en)	2012-09-07	2012-10-24	Cancer Rec Tech Ltd	Inhibitor compounds
EP3054936B1 (en)	2013-10-10	2023-10-18	Eastern Virginia Medical School	4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives as 12-lipoxygenase inhibitors
GB201403536D0 (en)	2014-02-28	2014-04-16	Cancer Rec Tech Ltd	Inhibitor compounds
AR101196A1 (es) *	2014-07-16	2016-11-30	Gruenenthal Gmbh	Compuestos de pirimidina sustituidos
GB201709840D0 (en)	2017-06-20	2017-08-02	Inst Of Cancer Research: Royal Cancer Hospital	Methods and medical uses

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4179563A (en) *	1978-05-19	1979-12-18	Warner-Lambert Company	3-Aryloxy-substituted-aminopyridines and methods for their production
WO1993020097A1 (en) *	1992-03-31	1993-10-14	British Technology Group Ltd.	17-substituted steroids useful in cancer treatment
PT892791E (pt) *	1996-04-12	2003-06-30	Searle & Co	N-¬¬4-(5-metil-3-fenilisoxazol-4-il\|fenil\|sulfonil-propilamida e seu sal de sodio como pro-farmacos de inibidores de cox-2
US5629325A (en) *	1996-06-06	1997-05-13	Abbott Laboratories	3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
GB9725782D0 (en) *	1997-12-05	1998-02-04	Pfizer Ltd	Therapeutic agents
CA2331878A1 (en) *	1998-05-14	1999-11-18	G.D. Searle & Co.	1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
DK1080070T3 (da) *	1998-05-22	2007-02-26	Abbott Lab	Antiangiogent lægemiddel til behandling af cancer, artritis og retinopati
DE69919361T2 (de) *	1998-08-25	2005-09-08	Ortho-Mcneil Pharmaceutical, Inc.	Pyridyl-ether und -thioether als nikotin-acetylcholin-rezeptorliganden und ihre therapeutische anwendung
SI1690853T1 (sl) *	1999-01-13	2010-07-30	Bayer Healthcare Llc	Uporaba omega-karboksiarilno substituiranih difenilsečnin kot inhibitorjev raf-kinaze
EP1140840B1 (en) *	1999-01-13	2006-03-22	Bayer Pharmaceuticals Corp.	-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
CO5170498A1 (es) *	1999-05-28	2002-06-27	Abbott Lab	Biaril sulfonamidas son utiles como inhibidores de proliferacion celular
JP2001114690A (ja) *	1999-08-06	2001-04-24	Takeda Chem Ind Ltd	ｐ３８ＭＡＰキナーゼ阻害剤
EP1212319A2 (en) *	1999-09-14	2002-06-12	Abbott Laboratories	3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
PT1230232E (pt) *	1999-11-05	2004-07-30	Cytovia Inc	4h-cromeno substituido e seus analogos como activadores de caspases e indutores de apoptose e sua utilizacao
HN2001000008A (es) *	2000-01-21	2003-12-11	Inc Agouron Pharmaceuticals	Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
DE60136530D1 (de) *	2000-03-01	2008-12-24	Janssen Pharmaceutica Nv	2,4-disubstituierte thiazolyl derivate

2002
- 2002-12-12 JP JP2003552299A patent/JP2005516927A/ja active Pending
- 2002-12-12 AU AU2002353147A patent/AU2002353147A1/en not_active Abandoned
- 2002-12-12 EP EP02790126A patent/EP1463505A2/en not_active Withdrawn
- 2002-12-12 CA CA002470214A patent/CA2470214A1/en not_active Abandoned
- 2002-12-13 TW TW91136090A patent/TW200301122A/zh unknown
2004
- 2004-06-14 MX MXPA04005810 patent/MXPA04005810A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2470214A1 (en)	2003-06-26
EP1463505A2 (en)	2004-10-06
JP2005516927A (ja)	2005-06-09
AU2002353147A8 (en)	2003-06-30
TW200301122A (en)	2003-07-01
MXPA04005810A (es)	2004-10-29

Similar Documents

Publication	Publication Date	Title
WO2003051366A3 (en)	2004-03-25	3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
IL157418A0 (en)	2004-03-28	3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
PL1635835T3 (pl)	2010-06-30	Pochodne 2-aminopirymidyny jako inhibitory kinazy RAF
AU2002310187A1 (en)	2002-12-09	Inhibitors of protein kinase for the treatment of disease
AU2002305205A1 (en)	2002-11-05	9-deazaguanine derivatives as inhibitors of gsk-3
AU2003243318A1 (en)	2003-12-19	Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer
IL174989A0 (en)	2006-08-20	4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer
IL159926A0 (en)	2004-06-20	Aminoisoxazole derivatives active as kinase inhibitors
PL363363A1 (en)	2004-11-15	Epothilone derivatives for the treatment of refractory tumors
MXPA03007394A (es)	2003-12-04	Tratamiento de tumores refractarios mediante uso de derivados de epotilona.
AU2002252227A1 (en)	2002-09-24	Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
AU2002353147A1 (en)	2003-06-30	3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
AU2002303145A1 (en)	2002-10-08	Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
AU2003268464A1 (en)	2004-03-29	INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
GB2410744B (en)	2006-04-12	Kinase inhibitors for the treatment of disease
AU2002334284A1 (en)	2003-05-12	1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
AU2002309243A1 (en)	2002-10-03	Heterocyclic compounds for therapeutic use
AU2002348440A1 (en)	2003-05-12	Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
HK1057482A (zh)	2004-04-08	Epothilone衍生物用於治疗肿瘤顽疾
HK1060291A (zh)	2004-08-06	使用埃普的龙(epothilone)衍生物治疗顽固性肿瘤
AU2002330983A1 (en)	2003-02-17	Pyrazolon derivatives as inhibitors of gsk-3
AU2002256153A1 (en)	2002-10-08	Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
AU2002318129A1 (en)	2002-11-18	Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
AU2002303147A1 (en)	2002-10-08	Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
AU2002254582A1 (en)	2002-10-08	Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases

Legal Events

Date	Code	Title	Description
2004-09-02	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase